Literature DB >> 27583395

Chorioamnionitis and subsequent bronchopulmonary dysplasia in very-low-birth weight infants: a 25-year cohort.

A R Ballard1, L H Mallett1, J E Pruszynski2, J B Cantey1.   

Abstract

OBJECTIVE: To determine whether chorioamnionitis (CA) or sepsis were associated with bronchopulmonary dysplasia (BPD) in a 25-year cohort of very-low-birth weight (VLBW) infants. STUDY
DESIGN: VLBW infants ⩽32 weeks gestation admitted to the neonatal intensive care unit between 1989 and 2014 were reviewed. BPD was defined using the National Institutes of Health consensus definition. CA was defined clinically. Logistic regression models were used for BPD prediction.
RESULTS: One thousand six hundred and eighty-seven infants were included; 44% (n=740) had moderate or severe BPD. In multivariable analysis, lower gestational age (odds ratio (OR) 1.12 per week (95% confidence interval (CI) 1.11, 1.14)), sepsis (OR 2.03 (95% CI 1.49, 2.77)) and birth year ⩾1995 (OR 1.49 (95% CI 1.09, 2.04)) were significant predictors of BPD. CA was not associated with BPD (OR 1.18 (95% CI 0.66, 2.11)).
CONCLUSION: Sepsis, but not CA, is associated with the development of moderate or severe BPD in VLBW infants after controlling for gestational age.

Entities:  

Mesh:

Year:  2016        PMID: 27583395     DOI: 10.1038/jp.2016.138

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  38 in total

1.  ACOG committee opinion. Antenatal corticosteroid therapy for fetal maturation. Number 210, October 1998 (Replaces Number 147, December 1994). Committee on Obstetric Practice. American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  1999-03       Impact factor: 3.561

2.  Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.

Authors:  Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2011-04-25       Impact factor: 7.124

3.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

Review 4.  Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia--the case in favour.

Authors:  Wolfgang Thomas; Christian P Speer
Journal:  Paediatr Respir Rev       Date:  2013-10-13       Impact factor: 2.726

5.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

Review 6.  Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis.

Authors:  Lisa Hartling; Yuanyuan Liang; Thierry Lacaze-Masmonteil
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2011-06-22       Impact factor: 5.747

7.  Risk Factors and Outcomes of Late-Onset Bacterial Sepsis in Preterm Neonates Born at < 32 Weeks' Gestation.

Authors:  Jyotsna Shah; Ann L Jefferies; Eugene W Yoon; Shoo K Lee; Prakesh S Shah
Journal:  Am J Perinatol       Date:  2014-12-08       Impact factor: 1.862

Review 8.  The Natural History of Bronchopulmonary Dysplasia: The Case for Primary Prevention.

Authors:  Cindy T McEvoy; Judy L Aschner
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

9.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.

Authors:  Barbara J Stoll; Nellie I Hansen; Edward F Bell; Michele C Walsh; Waldemar A Carlo; Seetha Shankaran; Abbot R Laptook; Pablo J Sánchez; Krisa P Van Meurs; Myra Wyckoff; Abhik Das; Ellen C Hale; M Bethany Ball; Nancy S Newman; Kurt Schibler; Brenda B Poindexter; Kathleen A Kennedy; C Michael Cotten; Kristi L Watterberg; Carl T D'Angio; Sara B DeMauro; William E Truog; Uday Devaskar; Rosemary D Higgins
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

10.  Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT).

Authors:  Timothy P Stevens; Neil N Finer; Waldemar A Carlo; Peter G Szilagyi; Dale L Phelps; Michele C Walsh; Marie G Gantz; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Jamie E Newman; Abhik Das; Barbara T Do; Kurt Schibler; Wade Rich; Nancy S Newman; Richard A Ehrenkranz; Myriam Peralta-Carcelen; Betty R Vohr; Deanne E Wilson-Costello; Kimberly Yolton; Roy J Heyne; Patricia W Evans; Yvonne E Vaucher; Ira Adams-Chapman; Elisabeth C McGowan; Anna Bodnar; Athina Pappas; Susan R Hintz; Michael J Acarregui; Janell Fuller; Ricki F Goldstein; Charles R Bauer; T Michael O'Shea; Gary J Myers; Rosemary D Higgins
Journal:  J Pediatr       Date:  2014-04-13       Impact factor: 4.406

View more
  20 in total

1.  Surfactant utilization and short-term outcomes in an era of non-invasive respiratory support in Canadian neonatal intensive care units.

Authors:  K Raghuram; A Mukerji; J Young; W Yee; M Seshia; K Dow; V Shah
Journal:  J Perinatol       Date:  2017-06-29       Impact factor: 2.521

Review 2.  Can We Understand the Pathobiology of Bronchopulmonary Dysplasia?

Authors:  Cristina M Alvira; Rory E Morty
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

Review 3.  Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology.

Authors:  Renjithkumar Kalikkot Thekkeveedu; Milenka Cuevas Guaman; Binoy Shivanna
Journal:  Respir Med       Date:  2017-10-24       Impact factor: 3.415

4.  Cognitive Development and Quality of Life Associated With BPD in 10-Year-Olds Born Preterm.

Authors:  Sudhir Sriram; Michael D Schreiber; Michael E Msall; Karl C K Kuban; Robert M Joseph; T Michael O' Shea; Elizabeth N Allred; Alan Leviton
Journal:  Pediatrics       Date:  2018-05-17       Impact factor: 7.124

5.  Consequences of early postnatal lipopolysaccharide exposure on developing lungs in mice.

Authors:  Amrit Kumar Shrestha; Matthew L Bettini; Renuka T Menon; Vashisht Y N Gopal; Shixia Huang; Dean P Edwards; Mohan Pammi; Roberto Barrios; Binoy Shivanna
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-11       Impact factor: 5.464

6.  Morbidity and mortality of coagulase-negative staphylococcal sepsis in very-low-birth-weight infants.

Authors:  Joseph B Cantey; Kelsey R Anderson; Ram R Kalagiri; Lea H Mallett
Journal:  World J Pediatr       Date:  2018-03-13       Impact factor: 2.764

7.  Adrenomedullin Deficiency Potentiates Lipopolysaccharide-Induced Experimental Bronchopulmonary Dysplasia in Neonatal Mice.

Authors:  Amrit K Shrestha; Renuka T Menon; Chandrasekhar Yallampalli; Roberto Barrios; Binoy Shivanna
Journal:  Am J Pathol       Date:  2021-09-09       Impact factor: 4.307

8.  Phenotypic overlap in neonatal respiratory morbidity following preterm premature rupture of membranes versus spontaneous preterm labor.

Authors:  Alisa Kachikis; Christie L Walker; Ryan M McAdams; Cynthia Gyamfi-Bannerman; Kristina M Adams Waldorf
Journal:  J Matern Fetal Neonatal Med       Date:  2019-08-11

Review 9.  Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes.

Authors:  Lauren M Davidson; Sara K Berkelhamer
Journal:  J Clin Med       Date:  2017-01-06       Impact factor: 4.241

Review 10.  Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies.

Authors:  Nicola Principi; Giada Maria Di Pietro; Susanna Esposito
Journal:  J Transl Med       Date:  2018-02-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.